ATE475098T1 - Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 - Google Patents

Verfahren zur messung von plasmaspiegeln von pentraxin ptx3

Info

Publication number
ATE475098T1
ATE475098T1 AT06842803T AT06842803T ATE475098T1 AT E475098 T1 ATE475098 T1 AT E475098T1 AT 06842803 T AT06842803 T AT 06842803T AT 06842803 T AT06842803 T AT 06842803T AT E475098 T1 ATE475098 T1 AT E475098T1
Authority
AT
Austria
Prior art keywords
ptx3
plasma levels
measuring plasma
pentraxin ptx3
plasma
Prior art date
Application number
AT06842803T
Other languages
English (en)
Inventor
Alberto Mantovani
Giuseppe Peri
Fabio Pasqualini
Original Assignee
Humanitas Mirasole Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humanitas Mirasole Spa filed Critical Humanitas Mirasole Spa
Application granted granted Critical
Publication of ATE475098T1 publication Critical patent/ATE475098T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002Partitioning blood components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Lasers (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
AT06842803T 2006-12-22 2006-12-22 Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 ATE475098T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2006/000872 WO2008078344A1 (en) 2006-12-22 2006-12-22 A method for measuring plasma levels of long pentraxin ptx3

Publications (1)

Publication Number Publication Date
ATE475098T1 true ATE475098T1 (de) 2010-08-15

Family

ID=38050157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06842803T ATE475098T1 (de) 2006-12-22 2006-12-22 Verfahren zur messung von plasmaspiegeln von pentraxin ptx3

Country Status (9)

Country Link
US (1) US20090317843A1 (de)
EP (1) EP2092342B1 (de)
JP (1) JP2010513917A (de)
CN (1) CN101606067A (de)
AT (1) ATE475098T1 (de)
AU (1) AU2006352299A1 (de)
CA (1) CA2671139A1 (de)
DE (1) DE602006015727D1 (de)
WO (1) WO2008078344A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5334742B2 (ja) * 2009-08-11 2013-11-06 関東化学株式会社 水溶性アンモニウムポリマーを含有する検体前処理試薬、および検体前処理方法
US20120034706A1 (en) * 2010-08-06 2012-02-09 Hakujyujikai Medical Inc. Method for assessing inflammatory condition
GB201309358D0 (en) 2013-05-24 2013-07-10 King S College London Aiding assessment of prognosis in inflammatory disease
MY160723A (en) * 2013-12-30 2017-03-15 Univ Putra Malaysia An anticoagulant
RU2018142073A (ru) * 2014-12-09 2019-01-10 Као Корпорейшн Санитарно-гигиеническое изделие и агент для обработки санитарно-гигиенического изделия
TWI741216B (zh) * 2017-09-19 2021-10-01 臻崴生物科技有限公司 專一性抑制或減緩ptx3與ptx3受體結合之單株抗體或其抗原結合片段及其用途
TWI754171B (zh) 2018-09-14 2022-02-01 臻崴生物科技有限公司 含單株抗體或其抗原結合片段之醫藥組成物及其用途
CN110514844A (zh) * 2019-08-14 2019-11-29 湖南山河生物医学技术孵化中心(有限合伙) 一种人五聚素3磁微粒化学发光免疫定量检测试剂盒及其制备方法
CN111024956A (zh) * 2019-12-31 2020-04-17 江苏美克医学技术有限公司 一种检测ptx3的时间分辨荧光免疫层析试剂盒
CA3230920A1 (en) * 2021-09-10 2023-03-16 Jason J. SUN Agglutinating agents, devices and methods for whole blood assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1325043A (en) * 1969-08-04 1973-08-01 Greenspan D J Method of separating blood components
US5652148A (en) * 1993-04-20 1997-07-29 Actimed Laboratories, Inc. Method and apparatus for red blood cell separation
FR2774473B1 (fr) * 1998-02-05 2000-05-12 Pasteur Sanofi Diagnostics Procede de dosage des troponines dans des milieux biologiques permettant d'eviter les interferences dues a l'heparine
JP2004510161A (ja) * 2000-09-25 2004-04-02 アボット・ラボラトリーズ 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
EP1720014A4 (de) * 2004-02-25 2008-01-16 Perseus Proteomics Inc Verfahren zur beurteilung des ausmasses einer vaskulopathie
ITMI20040858A1 (it) * 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
JP5199120B2 (ja) * 2005-12-29 2013-05-15 ヒューマニタス・ミラソーレ・エス.ピー.エー. 妊娠における炎症性内皮機能障害に対する診断試験

Also Published As

Publication number Publication date
EP2092342B1 (de) 2010-07-21
JP2010513917A (ja) 2010-04-30
US20090317843A1 (en) 2009-12-24
WO2008078344A1 (en) 2008-07-03
DE602006015727D1 (de) 2010-09-02
CA2671139A1 (en) 2008-07-03
AU2006352299A1 (en) 2008-07-03
EP2092342A1 (de) 2009-08-26
CN101606067A (zh) 2009-12-16

Similar Documents

Publication Publication Date Title
DE112008000683A5 (de) Messeinrichtung und Verfahren zur optischen Konzentrationsbestimmung von Blutzucker und/oder Laktat in biologischen Systemen
WO2008021290A8 (en) Organ-specific proteins and methods of their use
BR112012013362A2 (pt) sistema para a determinação de um valor para pelo menos um parâmetro que descreve a atividade microbiana de organismos biológicos individuais em uma amostra de líquido, e, método para a determinação da atividade microbiana em uma amostra de líquido
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
BRPI1007321A2 (pt) métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo.
BRPI0916624A2 (pt) anticorpos monoclonais seletivos anti-hepcidina-25, seus usos, bem como método e kit para quantificar a quantidade de proteína hepcidina-25 em uma amostra de tecido ou fluido biológico
EP2634573A3 (de) Kartuschenvorrichtung für ein Messsystem zur Messung der viskoelastischen Eigenschaften einer Probenflüssigkeit, zugehöriges Messsystem und zugehöriges Verfahren
ATE474228T1 (de) Reagenz für hämoglobinabbau
ATE525648T1 (de) Testelement mit nanofasern
EP2662453A3 (de) Nachweis und Behandlung von Schizophrenie
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
EP2081029A3 (de) Biomarker zur Diagnose diabetischer Retinopathie
EP3714276C0 (de) Testsensoren, systeme und analyseverfahren zur messung von glykiertem hämoglobin in unverdünnten blutproben
EP3736571A4 (de) Verfahren, reagenz und chip zur messung der analytkonzentration in einer biologischen probe
DE602007010246D1 (de) Verfahren zur blutgerinnungsbestimmung
DE602006018721D1 (de) Cyanidfreie lösungsmittelzusammensetzung und verwendungsverfahren dafür zur messung von hämoglobin und weissen blutkörperchen
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DE602007006671D1 (de) Verwendung von nnmt als marker für lungenkrebs
EP2259058A4 (de) Verfahren zur messung eines hämatokritwertes oder einer blutkomponentenkonzentration sowie entsprechendes messsystem
FI20040255A7 (fi) Menetelmä pre-eklampsian riskin havaitsemiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties